医学
甲氨蝶呤
血癌
免疫分型
化疗
内科学
淋巴瘤
中枢神经系统
间变性淋巴瘤激酶
长春新碱
疾病
肿瘤科
癌症
免疫学
环磷酰胺
抗原
胸腔积液
恶性胸腔积液
作者
Denise Williams,Tetsuya Mori,Alfred Reiter,Wilhelm Woessman,Angelo Rosolen,Grażyna Wróbel,József Zsíros,Anne Uyttebroeck,Ildikó Márky,Marie‐Cécile Le Deley,Laurence Brugières
摘要
Abstract In an international study of systemic childhood ALCL, 12/463 patients had CNS involvement, three of which had isolated CNS disease. Comparative analysis of CNS positive and negative patients showed no difference in ALK positivity, immunophenotype, presence of B symptoms or other sites of disease. The lymphohistiocytic variant was over represented in the CNS positive group (36% vs. 5%). With multi‐agent chemotherapy, including high dose methotrexate, Ara‐C and intrathecal treatment, the event free and overall survival of the CNS positive group at 5 years were 50% (95%CI, 25–75%) and 74% (45–91%), respectively with a median follow up of 4.1 years. Pediatr Blood Cancer 2013;60:E118–E121. © 2013 Wiley Periodicals, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI